Akso Health Group (AHG) Stock Price

Akso Health Group Price

NASDAQ·CLOSED
1.46USD+0.00 (+0.00 %)
Market closed

Revenue has compounded at 10.4% per year over the past 11 years to 13.83 M USD. Earnings per share have grown at 15.4% per year over the last 3 years. Akso Health Group's net margin stands at -135.0%, up from -267.0% several years earlier. Akso Health Group currently offers a dividend yield of about 82.19%. The payout ratio is around 10% of earnings. The stock trades about 26% above its 52-week low.

Akso Health Group stock price

Volume
Ex-Dividend
Details

Stock Price

ⓘ

How to Read This Chart

This chart tracks the historical stock price of Akso Health Group over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.

Total Return vs. Price Return

The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.

Intraday Price Data

When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Akso Health Group stock reacts to market openings, earnings releases, or breaking news throughout the trading session.

What to Look For

Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Akso Health Group's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.

Akso Health Group Stock Price History
DateAkso Health Group Price
7/29/20261.46 USD
7/28/20261.46 USD
7/27/20261.44 USD
7/23/20261.47 USD
7/22/20261.44 USD
7/21/20261.60 USD
7/20/20261.58 USD
7/17/20261.51 USD
7/16/20261.56 USD
7/15/20261.53 USD
7/14/20261.52 USD
7/13/20261.45 USD
7/10/20261.52 USD
7/9/20261.49 USD
7/8/20261.55 USD
7/7/20261.56 USD
7/6/20261.52 USD
7/2/20261.52 USD
7/1/20261.51 USD
6/30/20261.49 USD
6/29/20261.66 USD
6/26/20261.52 USD
6/25/20261.34 USD
6/24/20261.35 USD
6/23/20261.36 USD
6/22/20261.34 USD
6/18/20261.34 USD
6/17/20261.23 USD
6/16/20261.21 USD
6/15/20261.16 USD
6/12/20261.35 USD
6/11/20261.37 USD
6/10/20261.39 USD
6/9/20261.40 USD
6/5/20261.34 USD
6/4/20261.46 USD
6/3/20261.45 USD
6/2/20261.45 USD
6/1/20261.49 USD
5/29/20261.52 USD
5/28/20261.54 USD
5/27/20261.56 USD
5/26/20261.60 USD
5/22/20261.53 USD
5/21/20261.51 USD
5/20/20261.60 USD
5/19/20261.63 USD
5/14/20262.04 USD
4/22/20261.98 USD
4/21/20261.98 USD
4/20/20261.97 USD
4/17/20262.00 USD
4/16/20262.13 USD
4/15/20262.21 USD
4/14/20262.36 USD
4/13/20262.45 USD
4/9/20262.26 USD
4/8/20262.29 USD
4/7/20262.28 USD
4/6/20262.25 USD
4/2/20262.22 USD
4/1/20262.32 USD
3/31/20262.28 USD
3/30/20262.35 USD
3/27/20262.36 USD
3/26/20262.35 USD
3/25/20262.37 USD
3/24/20262.27 USD
3/23/20262.40 USD
3/20/20262.36 USD
3/19/20262.42 USD
3/18/20262.44 USD
3/17/20262.31 USD
3/16/20262.45 USD
3/13/20262.50 USD
3/12/20262.18 USD
3/11/20262.20 USD
3/10/20261.78 USD
3/9/20261.48 USD
3/5/20261.35 USD
3/4/20261.35 USD
3/3/20261.44 USD
3/2/20261.31 USD
2/27/20261.43 USD
2/26/20261.40 USD
2/25/20261.28 USD
2/24/20261.40 USD
2/23/20261.37 USD
2/20/20261.35 USD
2/19/20261.40 USD
2/17/20261.31 USD
2/13/20261.38 USD
2/12/20261.44 USD
2/11/20261.41 USD
2/10/20261.45 USD
2/9/20261.48 USD
2/6/20261.49 USD
2/5/20261.50 USD
2/4/20261.60 USD
2/3/20261.46 USD
2/2/20261.47 USD
1/30/20261.42 USD
1/29/20261.40 USD
1/28/20261.42 USD
1/27/20261.43 USD
1/26/20261.41 USD
1/23/20261.51 USD
1/22/20261.53 USD
1/21/20261.57 USD
1/20/20261.52 USD
1/16/20261.59 USD
1/15/20261.53 USD
1/14/20261.42 USD
1/13/20261.45 USD
1/12/20261.54 USD
1/9/20261.38 USD
1/8/20261.33 USD
1/7/20261.38 USD
1/6/20261.35 USD
1/5/20261.49 USD
1/2/20261.60 USD
12/31/20251.64 USD
12/30/20251.65 USD
12/29/20251.43 USD
12/26/20251.40 USD
12/24/20251.41 USD
12/23/20251.35 USD
12/22/20251.26 USD
12/19/20251.29 USD
12/18/20251.31 USD
12/17/20251.22 USD
12/16/20251.23 USD
12/15/20251.21 USD
12/12/20251.35 USD
12/11/20251.36 USD
12/10/20251.41 USD
12/9/20251.34 USD
12/8/20251.35 USD
12/5/20251.39 USD
12/4/20251.57 USD
12/3/20251.39 USD
12/2/20251.44 USD
12/1/20251.48 USD
11/28/20251.49 USD
11/26/20251.50 USD
11/25/20251.51 USD
11/24/20251.51 USD
11/21/20251.55 USD
11/20/20251.54 USD
11/19/20251.53 USD
11/18/20251.57 USD
11/17/20251.37 USD
11/14/20251.41 USD
11/13/20251.47 USD
11/12/20251.51 USD
11/11/20251.56 USD
11/10/20251.57 USD
11/7/20251.57 USD
11/6/20251.69 USD
11/5/20251.70 USD
11/4/20251.59 USD
11/3/20251.60 USD
10/31/20251.62 USD
10/30/20251.67 USD
10/29/20251.59 USD
10/28/20251.59 USD
10/27/20251.64 USD
10/23/20251.68 USD
10/22/20251.54 USD
10/21/20251.63 USD
10/20/20251.66 USD
10/16/20251.66 USD
10/15/20251.73 USD
10/14/20251.66 USD
10/13/20251.71 USD
10/9/20251.70 USD
10/8/20251.56 USD
10/7/20251.63 USD
10/6/20251.57 USD
10/2/20251.60 USD
10/1/20251.68 USD
9/30/20251.73 USD
9/29/20251.79 USD
9/25/20251.71 USD
9/24/20251.70 USD
9/23/20251.75 USD
9/22/20251.74 USD
9/18/20251.88 USD
9/17/20251.79 USD
9/16/20251.91 USD
9/15/20251.92 USD
9/11/20251.83 USD
9/10/20251.72 USD
9/9/20251.87 USD
9/8/20251.77 USD
9/4/20251.63 USD
9/3/20251.70 USD
9/2/20251.70 USD
8/28/20251.74 USD
8/27/20251.74 USD
8/26/20251.76 USD
8/25/20251.77 USD
8/21/20251.84 USD
8/20/20251.76 USD
8/19/20251.74 USD
8/18/20251.76 USD
8/14/20251.74 USD
8/13/20251.77 USD
8/12/20251.86 USD
8/11/20251.73 USD
8/7/20251.74 USD
8/6/20251.64 USD
8/5/20251.73 USD
8/4/20251.71 USD
Access this data via the Eulerpool API
Get Free API Key

Akso Health Group Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2023
13.18 M USD
-14.27 M USD
-1.36 M USD
Jan 1, 2024
2.41 M USD
-17.28 M USD
-9.46 M USD
Jan 1, 2025
14.78 M USD
-166.30 M USD
-134.98 M USD
Jan 1, 2026
13.83 M USD
-4.00 M USD
-18.67 M USD
Jan 1, 2027 (e)
108.28 M USD
-66.89 M USD
3.44 B USD
Jan 1, 2028 (e)
66.57 M USD
-41.13 M USD
-102.63 M USD
Jan 1, 2029 (e)
35.42 M USD
-21.88 M USD
-307.90 M USD
Jan 1, 2030 (e)
98.93 M USD
-61.11 M USD
2.21 B USD

Akso Health Group Income Statement, Balance Sheet, Cash Flow Statement

Last updated Aug 1, 2026, 5:39 PM
 
REVENUEM USD
REVENUE GROWTH%
GROSS MARGIN%
GROSS INCOMEM USD
EBITM USD
EBIT MARGIN%
NET INCOMEB USD
NET INCOME GROWTH%
DIV.USD
DIV. GROWTH%
SHARESB
2015201620172018201920202021202220232024202520262027e2028e2029e2030e
4.0011.0022.00107.0061.006.001.006.0013.002.0014.0013.00108.0066.0035.0098.00
–175.00100.00386.36-42.99-90.16-83.33500.00116.67-84.62600.00-7.14730.77-38.89-46.97180.00
75.0081.8277.2791.5986.89100.00100.0016.677.6950.007.147.697.697.697.697.69
3.009.0017.0098.0053.006.001.001.001.001.001.001.008.315.082.697.54
–4.009.0075.005.00-48.00-1.00-15.00-14.00-17.00-166.00-4.00-66.00-41.00-21.00-61.00
–36.3640.9170.098.20-800.00-100.00-250.00-107.69-850.00-1,185.71-30.77-61.11-62.12-60.00-62.24
––0.010.070.01-0.07-0.03-0.02–-0.01-0.13-0.023.44-0.10-0.312.21
––166.67712.50-92.31-1,520.00-52.11-52.94-93.75800.001,388.89-86.57-19,200.00-102.97200.98-818.57
–––0.401.20–––––––1.201.201.20–
––––200.00–––––––––––
–0.010.010.010.010.010.010.010.020.340.202.572.572.572.572.57
Details

Income Statement Key Figures

ⓘ

Revenue and Revenue Growth

Revenue is the starting point of every income statement — it measures the total sales Akso Health Group generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.

Gross Margin

Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Akso Health Group retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Akso Health Group's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.

EBIT and EBIT Margin

EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.

Net Income and Earnings Per Share (EPS)

Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.

Shares Outstanding

The total number of shares Akso Health Group has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.

Analyst Estimates

The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Akso Health Group's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.

Akso Health Group stock margins

The Akso Health Group margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Akso Health Group. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Akso Health Group.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2022
14.52 %
-239.79 %
-266.99 %
Jan 1, 2023
9.63 %
-108.23 %
-10.32 %
Jan 1, 2024
5.06 %
-715.56 %
-391.78 %
Jan 1, 2025
-1.91 %
-1,125.37 %
-913.38 %
Jan 1, 2026
-0.08 %
-28.92 %
-134.99 %
Jan 1, 2027 (e)
-0.08 %
-61.77 %
3,175.34 %
Jan 1, 2028 (e)
-0.08 %
-61.77 %
-154.16 %
Jan 1, 2029 (e)
-0.08 %
-61.77 %
-869.21 %

Akso Health Group Stock Revenue, EBIT, Earnings per Share

The Akso Health Group earnings per share therefore indicates how much revenue Akso Health Group has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue per Share
EBIT per share
Earnings per Share
Details
Date
Revenue per Share
EBIT per share
Earnings per Share
Jan 1, 2022
0.83 USD
-1.99 USD
-2.21 USD
Jan 1, 2023
0.55 USD
-0.60 USD
-0.06 USD
Jan 1, 2024
0.01 USD
-0.05 USD
-0.03 USD
Jan 1, 2025
0.08 USD
-0.85 USD
-0.69 USD
Jan 1, 2026
0.01 USD
-0.00 USD
-0.01 USD
Jan 1, 2027 (e)
0.13 USD
-0.03 USD
4.02 USD
Jan 1, 2028 (e)
0.08 USD
-0.02 USD
-0.12 USD
Jan 1, 2029 (e)
0.04 USD
-0.01 USD
-0.36 USD

Akso Health Group business model & stock analysis

Xiaobai Maimai Inc. is a Chinese company headquartered in Beijing. It was founded in 2016 by Xu Xiaoping, a well-known investment fund manager, and other businessmen. The company's name comes from Xu Xiaoping's childhood nickname, which means "little child." Xiaobai Maimai Inc.'s business model is diverse and includes various sectors such as e-commerce, education, culture, health, and social services. The company's main activities focus on providing online platforms and software applications for various purposes. The company offers a variety of products and services, including online marketplaces like Xiaobai Maimai Marketplace where consumers can purchase products and services from merchants. Xiaobai Maimai also operates Xiaobai Maimai University, an online learning platform where users can take courses on various topics taught by industry experts. Additionally, the company operates Xiaobai Health, an online platform for healthcare services where users can find information and advice on various health topics. This includes the sale of pharmacy products through an online store. The company is also involved in the cultural industry and operates an online platform for artistic services. Through the platform, businesses and individual customers can book artists and other entertainment services for their events. The story of Xiaobai Maimai Inc. began when Xu Xiaoping and his partners recognized the great need for online platforms in various industries in China. Due to the rapid growth of the Chinese economy in recent years, the demand for such platforms has been increasing. The company started with Xiaobai Maimai Marketplace and quickly expanded its activities to other areas. Since its inception, Xiaobai Maimai Inc. has received several investments, including a 150 million RMB investment from the Chinese government's fund for innovation and enterprise development. The company has also partnered with the Beijing Science and Technology Commission to promote innovation in the city. Overall, Xiaobai Maimai Inc. has had a significant impact on the Chinese economy and society in a short period. The company has helped meet the need for online platforms in various industries and has made a significant contribution to the digital transformation of the Chinese economy.

Akso Health Group SWOT Analysis

Strengths

One of the strengths of Xiaobai Maimai Inc is its strong brand recognition in the market. The company has established itself as a reliable and trustworthy platform for job seekers and employers.

Another strength is the user-friendly interface of Xiaobai Maimai's mobile application and website, which provides a seamless experience for users.

Furthermore, Xiaobai Maimai has a large user base, allowing for a wide pool of job opportunities and candidates.

Weaknesses

One weakness of Xiaobai Maimai Inc is its limited geographical presence. The platform primarily focuses on the Chinese job market and does not have a strong international presence.

Another weakness is the lack of diversified revenue streams. Xiaobai Maimai heavily relies on its job posting services as the main source of income, which poses a risk in case of any downturn in the job market.

Additionally, Xiaobai Maimai faces competition from other job recruitment platforms, which may impact its market share.

Opportunities

There are several opportunities for Xiaobai Maimai Inc to explore. The company can consider expanding its operations internationally to tap into global job markets.

With the rise of artificial intelligence and big data analytics, Xiaobai Maimai can leverage these technologies to improve its matching algorithms and provide more accurate job recommendations.

Furthermore, the company can explore partnerships with educational institutions or professional organizations to enhance its candidate pool and provide additional value-added services to users.

Threats

One of the threats Xiaobai Maimai Inc faces is the increasing competition in the job recruitment industry. The presence of well-established players and emerging startups may pose a challenge to the company's growth.

Another threat is the potential economic downturn or instability, which can lead to a decrease in job opportunities and hiring activities, impacting Xiaobai Maimai's revenue.

Moreover, data security and privacy concerns can undermine user trust and loyalty towards the platform, especially with the growing cybersecurity landscape.

Akso Health Group Employees

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Akso Health Group Employees
Details
Date
Akso Health Group Employees
Jan 1, 2019
- Employees
Jan 1, 2020
- Employees
Jan 1, 2021
- Employees
Jan 1, 2022
- Employees
Jan 1, 2023
- Employees
Jan 1, 2024
- Employees
Jan 1, 2025
- Employees
Jan 1, 2026
- Employees

Akso Health Group Eulerpool Fair Value

Details

Fair Value Estimate

ⓘ

What Is Fair Value?

Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.

Earnings-Based Fair Value

Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.

Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021

Revenue-Based Fair Value

Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"

Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021

Dividend-Based Fair Value

Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.

Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021

How to Use This Chart

When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.

Akso Health Group historical P/E ratio, EBIT multiple, and P/S ratio

Akso Health Group annual returns

Details

Annual Return

ⓘ

What This Chart Shows

This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.

Price Return

Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.

Dividend Return

Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.

What to Look For

Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.

Akso Health Group shares outstanding

The number of shares of Akso Health Group was 196.37 M in 2025. This indicates how many shares Akso Health Group is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Number of stocks
Details
Date
Number of stocks
Jan 1, 2022
7.62 M Stocks
Jan 1, 2023
23.83 M Stocks
Jan 1, 2024
337.18 M Stocks
Jan 1, 2025
196.37 M Stocks
Jan 1, 2026
2.57 B Stocks
Jan 1, 2027 (e)
2.57 B Stocks
Jan 1, 2028 (e)
2.57 B Stocks
Jan 1, 2029 (e)
2.57 B Stocks

Akso Health Group stock splits

In Akso Health Group's history, there have been no stock splits.

Akso Health Group Dividend History

2 years of dividend payments

YearAnnual DividendYoY ChangePayments
20191.20USD↑ 200.0%—
20180.40USD—1×

Akso Health Group dividend payout ratio

In 2025, Akso Health Group had a payout ratio of 9.96%. The payout ratio indicates the percentage of the company's profits that Akso Health Group distributes as dividends.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Payout ratio
Details
Date
Payout ratio
Jan 1, 2022
9.96 %
Jan 1, 2023
9.96 %
Jan 1, 2024
9.96 %
Jan 1, 2025
9.96 %
Jan 1, 2026
9.96 %
Jan 1, 2027 (e)
29.85 %
Jan 1, 2028 (e)
16.59 %
Jan 1, 2029 (e)
18.80 %
Price targets and forecasts for Akso Health Group are not yet available.

Akso Health Group shareholder structure

% Name
0.01150%
RENAISSANCE TECHNOLOGIES LLC
RENAISSANCE TECHNOLOGIES LLC
0.00548%
NORTHERN TRUST CORP
NORTHERN TRUST CORP
0.00414%
SmartHarvest Portfolios, LLC
SmartHarvest Portfolios, LLC
0.00365%
JANE STREET GROUP, LLC
JANE STREET GROUP, LLC
0.00175%
GEODE CAPITAL MANAGEMENT, LLC
GEODE CAPITAL MANAGEMENT, LLC
0.00000%
BLACKROCK, INC.
BLACKROCK, INC.

Akso Health Group Beneficial Ownership Filings (SEC 13D/G)

Free Float
99.0%
Float Shares
-
Shares Outstanding
-
StakeHolderFiling
60.96%
Webao Limited
Webao Limited
SEC ↗
8.02%
Xiaoning An
Xiaoning An
SEC ↗
8.02%
AnHe Holding Limited
AnHe Holding Limited
SEC ↗

Akso Health Group Executives and Management Board

XA

Mr. Xiaobo An

(38)

Chairman of the Board, Chief Executive Officer

RZ

Ms. Rui Zhang

(38)

Chief Financial Officer

WL

Ms. Wenjuan Liu

(35)

Director

DG

Mr. Dagang Guo

(49)

Independent Director

SM

Mr. Stephen Markscheid

(69)

Independent Director

Frequently asked questions about Akso Health Group

Xiaobai Maimai Inc represents values of innovation, integrity, and customer-centricity. With a strong corporate philosophy, the company strives to provide innovative solutions and improve the accessibility of financial services for individuals. Xiaobai Maimai Inc believes in fostering trust through transparent and ethical business practices, ensuring the satisfaction and trust of its customers. By integrating technology and finance, the company aims to empower individuals to achieve their financial goals conveniently and efficiently.

All fundamentals and in-depth analysis of Akso Health Group

Our stock analysis for Akso Health Group stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Akso Health Group. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.

Akso Health Group Stock
Akso Health Group Revenue→
Akso Health Group Stock
Akso Health Group Net Income→
Akso Health Group Stock
Akso Health Group P/E→
Akso Health Group Stock
Akso Health Group P/S→
Akso Health Group Stock
Akso Health Group EBIT→
Akso Health Group Stock
Akso Health Group Dividend→
Akso Health Group Stock
Akso Health Group Directors Dealings→
Akso Health Group Stock
Akso Health Group Stocks→
Akso Health Group Stock
Akso Health Group Market capitalization→
Akso Health Group Stock
Akso Health Group Debt→
Akso Health Group Stock
Akso Health Group Liabilities→
Akso Health Group Stock
Akso Health Group Equity→
Akso Health Group Stock
Akso Health Group AAQS→
Akso Health Group Stock
Akso Health Group Employees→
Akso Health Group Stock
Akso Health Group ROE→
Akso Health Group Stock
Akso Health Group ROA→
Akso Health Group Stock
Akso Health Group ROCE→
Akso Health Group Stock
Akso Health Group News→
Akso Health Group Stock
Akso Health Group Analyst Price Targets→

Finance Stocks

Aktia Bank AbpAkme Fintrade IndiaAl Ahleia Insurance Co SAKPAKKO Invest NyrtAl Ahli Bank of Kuwait KSCPAkita BankAl Ahly for Development and Investment SAEAkiko Global ServicesAl Baraka Bank Egypt SAEAker AAl Etihad Cooperative Insurance Company SJSCAkatsukiAll Stocks A–Z →